Viona Pharmaceuticals Inc. has confirmed the approval of its Abbreviated New Drug Application for METFORMIN HYDROCHLORIDE (ANDA077060), a critical ora...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves Watson Labs Generic Drug Application Watson Labs received FDA approval for abbreviated new drug application ANDA076417 on April 18, 20...
Zydus Pharmaceuticals USA has received FDA approval for ANDA077064, permitting the launch of a new generic drug. This regulatory clearance positions t...
On April 12, 2005, the U.S. FDA approved Actavis Labs FL Inc.'s ANDA for a new generic drug, signaling an impending entry of a branded competitor to t...
Sun Pharmaceutical Industries, Inc. announced the approval to manufacture and market Ciclopirox Olamine following the FDA's greenlight of ANDA 076790....
On April 12, 2005, Teva Pharmaceutical Industries received approval for Abbreviated New Drug Application #ANDA076864, signaling the company’s continue...
E.R. Squibb & Sons, L.L.C. received FDA approval for Baraclude (entecavir) oral tablets in March 2005, positioning it as a potent therapeutic option f...
E.R. Squibb & Sons, L.L.C. received FDA approval on March 29, 2005, for BARACLUDE (entecavir), an oral antiviral indicated for the treatment of chroni...
Mylan Pharmaceuticals Inc. received FDA approval for its Abbreviated New Drug Application for transdermal fentanyl, authorizing the launch of a generi...
Aurobindo Pharma has received FDA approval for its abbreviated new drug application (ANDA) for Metformin Hydrochloride, signaling a new entry for this...
Uronova Pharmaceuticals’ approval of its subcutaneous leuprolide acetate injection introduces new competition in the hormone therapy market, providing...
Sandoz received FDA approval on December 14, 2004, for its Abbreviated New Drug Application (ANDA076223), signaling a significant move downstream in t...
Sandoz has secured FDA approval for Abbreviated New Drug Application (ANDA) ANDA076873 on December 14, 2004, which will allow the company to immediate...
APOTEX has received approval from the US Food and Drug Administration for ANDA076706, a move that grants the company entry into the established market...
Watson Labs Inc. received FDA approval for ANDA076818 on December 14, 2004, marking another successful entry into the market as a pharmaceutical gener...
Hikma Pharmaceuticals USA Inc. has announced the initiation of 180-day generic exclusivity for lithium carbonate oral tablets, replacing the Teva bran...
Chattem, Inc. has secured approval for the new combination form of ALLEGRA-D ALLERGY AND CONGESTION, featuring fexofenadine hydrochloride and pseudoep...
Barr Laboratories announced on October 14, 2004, that its Abbreviated New Drug Application for demeclocycline hydrochloride tablets was approved by th...
Teva Pharmaceutical has announced the U.S. Food and Drug Administration's approval of an Abbreviated New Drug Application, potentially unlocking signi...
# FDA Approves Hikma Pharmaceuticals' Intravenous Allopurinol Sodium Formulation Hikma Pharmaceuticals USA Inc. received FDA approval for allopurinol...